ATE346864T1 - Mu-1, ein mitglied der cytokine rezeptor familie - Google Patents
Mu-1, ein mitglied der cytokine rezeptor familieInfo
- Publication number
- ATE346864T1 ATE346864T1 AT01937340T AT01937340T ATE346864T1 AT E346864 T1 ATE346864 T1 AT E346864T1 AT 01937340 T AT01937340 T AT 01937340T AT 01937340 T AT01937340 T AT 01937340T AT E346864 T1 ATE346864 T1 AT E346864T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor family
- cytokine receptor
- disclosed
- fragments
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56938400A | 2000-05-11 | 2000-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE346864T1 true ATE346864T1 (de) | 2006-12-15 |
Family
ID=24275231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01937340T ATE346864T1 (de) | 2000-05-11 | 2001-05-11 | Mu-1, ein mitglied der cytokine rezeptor familie |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP1353953B1 (de) |
JP (3) | JP2004500845A (de) |
AT (1) | ATE346864T1 (de) |
AU (2) | AU6308801A (de) |
CY (1) | CY1107339T1 (de) |
DE (1) | DE60124954T2 (de) |
DK (1) | DK1353953T3 (de) |
ES (1) | ES2276795T3 (de) |
PT (1) | PT1353953E (de) |
WO (1) | WO2001085792A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057128A (en) | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
EP1432431B1 (de) | 2001-10-04 | 2017-05-10 | Genetics Institute LLC | Verfahren und zusammensetzungen zur modulierung der wirkung des interleukin-21 |
EP1474515A2 (de) * | 2002-02-01 | 2004-11-10 | Bayer HealthCare AG | Regulierung eines menschlichen hematopoietin rezeptor ähnlichen proteins |
WO2004007682A2 (en) | 2002-07-15 | 2004-01-22 | Wyeth | Methods and compositions for modulating t helper (th) cell development and function |
EP1449883A1 (de) * | 2003-02-18 | 2004-08-25 | Corus Technology BV | Verpackungslagen aus Polymer mit besseren Trenneigenschaften |
RU2005131852A (ru) | 2003-03-14 | 2006-04-20 | Уайт (Us) | Антитела против человеческого рецептора il-21 и их применение |
GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
PE20100141A1 (es) | 2008-05-23 | 2010-02-22 | Wyeth Corp | Proteina de union al receptor de interleuquina 21 |
CN102149403A (zh) | 2008-05-23 | 2011-08-10 | 惠氏有限责任公司 | 利用白介素-21受体结合蛋白的治疗方法 |
JP2012504939A (ja) | 2008-09-23 | 2012-03-01 | ワイス・エルエルシー | 架橋結合タンパク質による活性化シグナルの産生を予測するための方法 |
WO2015110930A1 (en) | 2014-01-24 | 2015-07-30 | Pfizer Inc. | Modified interleukin 21 receptor proteins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057128A (en) * | 1998-03-17 | 2000-05-02 | Genetics Institute, Inc. | MU-1, member of the cytokine receptor family |
AU759689B2 (en) * | 1998-06-24 | 2003-04-17 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor proteins |
DK1115862T3 (da) * | 1998-09-23 | 2009-11-16 | Zymogenetics Inc | Cytokinreceptor Zalpha11 |
WO2000069880A1 (en) * | 1999-05-18 | 2000-11-23 | Millennium Pharmaceuticals, Inc. | Il-9/il-2 receptor-like molecules and uses thereof |
DE60125543T2 (de) * | 2000-04-05 | 2007-10-04 | Zymogenetics, Inc., Seattle | Löslicher zytokinrezeptor zalpha11 |
-
2001
- 2001-05-11 AU AU6308801A patent/AU6308801A/xx active Pending
- 2001-05-11 PT PT01937340T patent/PT1353953E/pt unknown
- 2001-05-11 AT AT01937340T patent/ATE346864T1/de active
- 2001-05-11 ES ES01937340T patent/ES2276795T3/es not_active Expired - Lifetime
- 2001-05-11 DE DE60124954T patent/DE60124954T2/de not_active Expired - Lifetime
- 2001-05-11 EP EP01937340A patent/EP1353953B1/de not_active Expired - Lifetime
- 2001-05-11 JP JP2001582391A patent/JP2004500845A/ja active Pending
- 2001-05-11 WO PCT/US2001/015395 patent/WO2001085792A2/en active IP Right Grant
- 2001-05-11 DK DK01937340T patent/DK1353953T3/da active
- 2001-05-11 AU AU2001263088A patent/AU2001263088B2/en not_active Expired
- 2001-05-11 EP EP06124726A patent/EP1787997A1/de not_active Withdrawn
-
2007
- 2007-02-20 CY CY20071100239T patent/CY1107339T1/el unknown
-
2008
- 2008-06-19 JP JP2008161010A patent/JP2009019037A/ja active Pending
-
2011
- 2011-12-27 JP JP2011286773A patent/JP5763518B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE60124954T2 (de) | 2007-09-20 |
JP2009019037A (ja) | 2009-01-29 |
ES2276795T3 (es) | 2007-07-01 |
EP1353953A2 (de) | 2003-10-22 |
EP1353953B1 (de) | 2006-11-29 |
JP5763518B2 (ja) | 2015-08-12 |
AU2001263088C1 (en) | 2001-11-20 |
EP1787997A1 (de) | 2007-05-23 |
WO2001085792A3 (en) | 2003-08-21 |
PT1353953E (pt) | 2007-02-28 |
DE60124954D1 (de) | 2007-01-11 |
WO2001085792A2 (en) | 2001-11-15 |
WO2001085792A8 (en) | 2002-05-23 |
AU2001263088B2 (en) | 2006-07-20 |
JP2004500845A (ja) | 2004-01-15 |
CY1107339T1 (el) | 2012-12-19 |
AU6308801A (en) | 2001-11-20 |
JP2012061009A (ja) | 2012-03-29 |
DK1353953T3 (da) | 2007-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE313626T1 (de) | Mu-1, ein mitglied der zytokinrezeptor-familie | |
CY1107339T1 (el) | Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης | |
HK1131744A1 (en) | Toll like receptor 3 antagonists, methods and uses toll | |
IL200404A0 (en) | 191P4D12(b) PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME; ANTIBODIES BINDING THERETO AND USES THEREOF | |
NO995458L (no) | Humane 12-lignende reseptorproteiner, beslektede reagenser og metoder | |
WO2002002636A3 (en) | Membrane associated protein zupari | |
NO20054836L (no) | Nogo-reseptorbindingsprotein | |
ATE212055T1 (de) | Östrogen-rezeptor | |
DE69202936T2 (de) | Hochtemperaturfester, keramischer Verbundstoff. | |
DK1141286T3 (da) | Kæde af cytokinreceptorer | |
ATE390482T1 (de) | Interleukin-1 hy2. mittel und verfahren | |
WO2002064630A3 (en) | Il-1 receptor accessory protein | |
EP0879879A3 (de) | Polypeptid-Deformylase 1 (Def1) | |
EP0911409A3 (de) | Deformylase | |
DE60107431D1 (de) | Ein neues mitglied der epha-rezeptor familie | |
EP0913474A3 (de) | DbpA, eine Helikase aus Staphylococcus aureus | |
ATE320496T1 (de) | Testisspezifische, menschliche proteinase, svph1- 8 | |
EP0927763A3 (de) | Neues aroA | |
NO20011961D0 (no) | PRV-1-genet og anvendelsen av dette | |
WO2000037634A3 (en) | Novel polypeptides and nucleic acids encoding same | |
EP0916727A3 (de) | Neues LysS | |
NO905542L (no) | Tienobenzoksepin- og naftotiofenderivater, fremgangsmaate og mellomprodukter for fremstilling derav. | |
EP0894862A3 (de) | Neues CysS | |
EP0906957A3 (de) | Lgt Polypeptid | |
WO2003040371A1 (fr) | Nouvelle proteine du recepteur couple a la proteine g et adn associe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1353953 Country of ref document: EP |